Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-063392
Filing Date
2022-05-20
Accepted
2022-05-20 16:27:11
Documents
1
Period of Report
2022-05-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2216239-2_4seq.html 4  
1 OWNERSHIP DOCUMENT tm2216239-2_4seq.xml 4 3098
  Complete submission text file 0001104659-22-063392.txt   4608
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
RVL Pharmaceuticals plc (Issuer) CIK: 0001739426 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address
Klein Christopher (Reporting) CIK: 0001755264 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38709 | Film No.: 22947969